Our functional analyses of a common exon-2 (p.G12A) and of the uncommon exon-4 (p.A146T, p.A146V) KRAS mutations therefore underscored their context-dependent capacity to activate and/or sustain oncogenic RAS/MAPK and AKT signaling in MM cells. This evidence concerns the gene KRAS and Miyoshi myopathy.